Reports showing that as an inhibitor of TGF-β type I receptor kinase activity, SB-431542 inhibits TGF-β-induced contraction of collagen gels by normal and keloid fibroblasts [18,19], thus suggesting that this compound may have therapeutic potential for treating excessive skin contraction that occurs in keloids. Here, TGFB1 is linked to keloid.